The risk of ectopic pregnancy following GnRH agonist triggering compared with hCG triggering in GnRH antagonist ivf cycles

The association between polycystic ovary syndrome and ectopic pregnancy after in vitro fertilization and embryo transfer

(2013) Jing Wang et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression

(2013) Alfonso Bermejo et al.   FERTILITY AND STERILITY

Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study

(2013) S. Iliodromiti et al.   HUMAN REPRODUCTION

Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study

(2013) Stamatina Iliodromiti et al.   Journal of Ovarian Research

Influence of controlled ovarian hyperstimulation on uterine peristalsis in infertile women

(2012) Lin Zhu et al.   HUMAN REPRODUCTION

Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles

(2012) P. Humaidan et al.   HUMAN REPRODUCTION

Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support

(2012) T. Imbar et al.   HUMAN REPRODUCTION

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

(2012) Ze Wu et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help?

(2012) Raoul Orvieto   REPRODUCTIVE BIOMEDICINE ONLINE

Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist

(2011) Nicole Kummer et al.   FERTILITY AND STERILITY

Ectopic pregnancy after assisted reproductive technology: what are the risk factors?

(2010) Hye Jin Chang et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango?

(2010) Shahar Kol et al.   REPRODUCTIVE BIOMEDICINE ONLINE

GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation

(2010) Kutluk Oktay et al.   REPRODUCTIVE BIOMEDICINE ONLINE

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study

(2009) Peter Humaidan et al.   FERTILITY AND STERILITY

GnRHa to trigger final oocyte maturation: a time to reconsider

(2009) P. Humaidan et al.   HUMAN REPRODUCTION

Elective Single Embryo Transfer: Guidelines for Practice British Fertility Society and Association of Clinical Embryologists

(2008) Rachel Cutting et al.   Human Fertility

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

(2007) Lawrence Engmann et al.   FERTILITY AND STERILITY